9 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
12 Feb 24
Regulation FD Disclosure
4:15pm
Hariri established that a range of stem, progenitor, and differentiated cell types could be isolated from the biological waste product of full-term … pregnancies for potential uses, including the then-emerging field of cell therapy. The same biological waste product likewise can serve as a source
8-K
EX-10.5
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
, including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters.
“ERISA” means
8-K
EX-10.1
CELU
Celularity Inc - Ordinary Shares
25 Aug 23
Entry into a Material Definitive Agreement
4:06pm
into the environment, including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters.
“ERISA
8-K
EX-10.1
CELU
Celularity Inc - Ordinary Shares
21 Jun 23
Entry into a Material Definitive Agreement
4:17pm
materials into the environment, including those related to hazardous materials, air emissions, discharges to waste or public systems and health
8-K
EX-10.1
hq9qsj 4oim47
16 May 23
Entry into a Material Definitive Agreement
4:48pm
S-4
EX-10.32
1q6hh5 d8vr23d0
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-2.1
rxk x7nf9xk
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
7c5mdv91dw5hmbups
8 Jan 21
Business combination disclosure
7:02am
- Prev
- 1
- Next